Advertisement

Topics

Latest "Indiana Blood and Marrow Transplantation" News Stories

08:54 EDT 16th July 2018 | BioPortfolio

Here are the most relevant search results for "Indiana Blood and Marrow Transplantation" found in our extensive news archives from over 250 global news sources.

More Information about Indiana Blood and Marrow Transplantation on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Indiana Blood and Marrow Transplantation for you to read. Along with our medical data and news we also list Indiana Blood and Marrow Transplantation Clinical Trials, which are updated daily. BioPortfolio also has a large database of Indiana Blood and Marrow Transplantation Companies for you to search.

Showing "Indiana Blood Marrow Transplantation" News Articles 1–25 of 5,500+

Monday 16th July 2018

Eureka Expands Scientific Advisory Board Members with Addition of Cytokine Release Syndrome (CRS) Experts Stephan A. Grupp, M.D., Ph.D. and Cameron J. Turtle, MBBS, Ph.D., FRACP, FRCPA

Eureka Therapeutics, Inc., a clinical stage biopharmaceutical company with the goal of curing cancer by developing novel T-cell therapies that harness the evolutionary power of the immune system, today announced that Stephan A. Grupp, M.D., Ph.D. of the Children’s Hospital of Philadelphia (CHOP) and Cameron J. Turtle, MBBS, Ph.D., FRACP, FRCPA of the Fre...


Disease-Modifying Therapies in RA and Blood Pressure Changes

A new study examines the impact of the initiation of disease-modifying therapies on blood pressure among patients with rheumatoid arthritis. Journal of Clinical Rheumatology

Bioasis Announces Non-Brokered Private Placement

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES BIOASIS TECHNOLOGIES INC. (TSX.V:BTI; OTCQB:BIOAF) (“Bioasis” or the “Company”), a biopharmaceutical company developing its xB3 proprietary platform technology for the delivery of therapeutics across the blood-brain barrier (BBB) ...


Vizuri Health Sciences LLC Granted New US Patent for Novel Topical Analgesic Formulations Containing Capsaicin

Vizuri Health Sciences LLC, a pharmaceutical and over-the-counter (OTC) product development company, today announced the issuance of a U.S. patent that further protects its capsaicin-based product pipeline. Newly issued

EMEA InVitro Diagnostics Market Segmented by Type of Technique, Product, Application and End Users Growth, Trends and Forecasts 2018 2023 [Report Updated: 08022018] Prices from USD $1922

The EMEA InVitro Diagnostics market is expected to register a CAGR of 5.89% during the forecast period 2018 to 2023. Due to increasing incidences of chronic diseases such as obesity related illness and rapid adoption of point of care testing, the Invitro diagnostics market in EMEA is expected to grow rapidly in the forecast period. Increasing Incidences of Chronic DiseasesAccording to World Healt...

20182023 Philippines Cytotoxic Drug Market Report Status and Outlook [Report Updated: 05032018] Prices from USD $3360

In 2017, the Cytotoxic Drug market size was xx million USD in Philippines, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023.In Philippines market, the top players include Roche Eli Lilly Celgene Sanofi eisai Sumitomo Dainippon Pharma Merck Seattle Genetics Takeda Haosoh Pharma Novartis AstraZeneca Jazz Pharma Spectrum PharmaS...

New Study Investigates the Utility of Masimo PVi® as Part of Goal-Directed Fluid Management in Patients Undergoing Colorectal Surgery

Masimo (NASDAQ: MASI) announced today the findings of a recently published study in which researchers at Kocaeli University in Turkey compared the performance of conventional fluid management (CFM) to goal-directed fluid management (GDFM) using Masimo PVi® (pleth variability index, measured noninvasively and continuously using SET® pulse oximetry...

Sunday 15th July 2018

Researchers to investigate role of hormones in mosquito's ability to use human blood for egg production

Entomologists at the University of California, Riverside have received a five-year grant of $2.44 million from the National Institute of Allergy and Infectious Diseases, or NIAID, to investigate the role hormones play in the female mosquito's ability to use human blood for egg production.

Residential segregation linked with racial disparities in firearm homicide fatalities

Residential segregation is linked to many racial disparities in health, including cancer, high blood pressure, and diabetes.

Study shows painful eczema symptoms negatively impact quality of life

(American College of Allergy, Asthma, and Immunology) A new study published in Annals of Allergy, Asthma and Immunology shows that eczema symptoms can have a profoundly negative impact on quality of life for those who suffer -- even worse than for those with common chronic illnesses like heart disease, diabetes and high blood pressure.

Traumatic brain injury biomarker shows promise to support rapid damage evaluation and predict outcomes

(Elsevier) A new study in The American Journal of Pathology found that a brain lipid molecule, lysophosphatidic acid (LPA), was significantly increased after traumatic brain injury (TBI) in a preclinical animal model. They also found that it was elevated in areas associated with cell death and axonal injury, both major hallmarks of moderate and severe TBI. This strengthens the evidence that LPA c...

Global Anesthesia Respiratory Devices Market Segmented by Product Type, Application, Marker Type and Geography Growth, Trends and Forecasts 2018 2023 [Report Updated: 08022018] Prices from USD $4250

As of 2017, the market for anesthetic respiratory devices reached a value of USD 20.5 billion. This market is expected to reach USD 36.9 billion by 2023, at a CAGR of about 10.29% during 20182023 the forecast period. Increasing Number of Surgeries The demand for various anesthetic drugs is directly related to the number of surgeries performed. Anesthesia is a necessity in almost every type of sur...

EMEA InVitro Diagnostics Market Segmented by Type of Technique, Product, Application and End Users Growth, Trends and Forecasts 2018 2023 [Report Updated: 08022018] Prices from USD $3850

The EMEA InVitro Diagnostics market is expected to register a CAGR of 5.89% during the forecast period 2018 to 2023. Due to increasing incidences of chronic diseases such as obesity related illness and rapid adoption of point of care testing, the Invitro diagnostics market in EMEA is expected to grow rapidly in the forecast period. Increasing Incidences of Chronic DiseasesAccording to World Healt...

Global 3D Cell Culture Market Segmented by Technology, Application and EndUser Growth, Trends and Forecasts 2018 2023 [Report Updated: 08022018] Prices from USD $4250

The global 3D Cell Culture market has been estimated to reach USD 682.8 million in 2017. The market is expected to register a CAGR of 20.3% during the forecast period, 2018 to 2023. North America dominates the market due to the incidence of cancer, and availability of wellestablished pharmaceutical and biotechnology industries. Rising Need for Organ TransplantationCell culture is a process to grow...

Saturday 14th July 2018

Global Extra Corporeal Membrane Oxygenation ECMO Market Segmented by Application and Modality Growth, Trends and Forecasts 2018 2023 [Report Updated: 08022018] Prices from USD $1923

Extra corporeal membrane oxygenation market is for the patient that are suffering from both the heart failure and lung failure which acts as a cardiac and respiratory support. An ECMO machine works as a bypass for the heart and lungs which purifies the blood outside the human body. The global extra corporeal membrane oxygenation market is expected to register a CAGR of 3.6% during the forecast per...

Global Extra Corporeal Membrane Oxygenation ECMO Market Segmented by Application and Modality Growth, Trends and Forecasts 2018 2023 [Report Updated: 08022018] Prices from USD $4250

Extra corporeal membrane oxygenation market is for the patient that are suffering from both the heart failure and lung failure which acts as a cardiac and respiratory support. An ECMO machine works as a bypass for the heart and lungs which purifies the blood outside the human body. The global extra corporeal membrane oxygenation market is expected to register a CAGR of 3.6% during the forecast per...

New Therapies Needed To Eradicate HIV

Currently approved anti-HIV drug combinations are remarkably effective at reducing the amount of HIV in many patients to undetectable blood levels...

Friday 13th July 2018

Global Renal Anemia Therapeutics Market 2018-2022 | Market Growth Analysis and Forecast | Technavio

Technavio analysts forecast the global renal anemia therapeutics market to grow at a CAGR of over 8% during the forecast period, according to their latest market research report. This press release features multimedia. View the full release here:

FDA announces voluntary recall of several medicines containing valsartan following detection of an impurity

FDA is alerting the public about a voluntary recall of several drug products containing valsartan, used to treat high blood pressure and heart failure

Jul 13, 2018 This Week in Cardiology

Questionable ICD use, ambulatory blood pressure monitoring, multivitamins and cardiovascular health, and end-of-life care are discussed in this week's podcast theheart.org on Medscape

New Research Shows Promise in Regional Delivery of CAR-T Therapy

Authors conclude novel delivery devices should be developed in conjunction with CAR-T therapies Surefire Medical, Inc. (Surefire), an oncology drug delivery company, announced the publication of “Regional Infusion of Chimeric Antigen Receptor T Cells to Overcome Barriers for Solid Tumor Immunotherapy” in the ISSUE of the Journal of Intervent...

FDA lifts hold on Aptose blood cancer candidate

Blacks Have Elevated HTN Risk Through Age 55 Years

FRIDAY, July 13, 2018 -- Blacks have considerably increased risk for hypertension than whites through age 55 years, regardless of blood pressure levels through young adulthood, according to a study published online July 11 in the Journal of the...

Global Colorectal Cancer Screening Market Segmented by Test Type Growth, Trends and Forecasts 2018 2023 [Report Updated: 08022018] Prices from USD $1923

The global market for colorectal cancer screening has been estimated at USD 727.08 million for 2017. The market is expected to register a CAGR of 4.38% during the forecast period, 2018 to 2023. AsiaPacific is expected to have a substantial growth in the forecast period. The Advent of Efficacious Genetic TestsGenetic testing for colon cancer creates better opportunity for early diagnosis. It is hig...

AbbVie raises hopes for blood cancer patients

AbbVie has filed its Venclexta (venetoclax) for a new use that it hopes could change the treatment of one of the most aggressive cancers – acute myeloid leukaemia (AML). Developed in partnership with Roche, Venclexta is already approved in the US ...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks